RxDoctor Payments Data

Michael Couser, DO

Family Medicine · Rutherfordton, NCNPI 1891316451

Payments from drug & device makers

$1,114in general payments, 2019–2025

Across 61 payments — averaging $18.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$166
  • AbbVie$163
  • Axsome Therapeutics, Inc.$114
  • Exact Sciences$111
  • Boehringer Ingelheim$78
  • Pfizer$76
  • plus $406 from 12 others

What the payments were for

  • Food & beverage$1,114100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,114 in reported general payments places this provider in the 70th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$40,431
Medicare patients
154
Services billed
1,131

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide95$95,744
JardianceEmpagliflozin49$44,666
EliquisApixaban40$40,284
XareltoRivaroxaban29$29,203
Trelegy ElliptaFluticasone/Umeclidin/Vilanter31$28,347
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog20$13,999
EntrestoSacubitril/Valsartan13$12,734
TrulicityDulaglutide12$11,440
Tresiba Flextouch U-100Insulin Degludec12$6,465
SymbicortBudesonide/Formoterol Fumarate15$5,602
Fluticasone-SalmeterolFluticasone Propion/Salmeterol20$2,389
Duloxetine Hcl130$2,341
Albuterol Sulfate HfaAlbuterol Sulfate104$2,163
Omeprazole173$1,882
Gabapentin128$1,757

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$166$95,74495 claims
Boehringer IngelheimJardiance$78$44,66649 claims
PfizerEliquis$76$40,28440 claims
GSKTrelegy Ellipta$16$28,34731 claims
Lilly USA, LLCTrulicity$44$11,44012 claims
AstraZenecaSymbicort$28$5,60215 claims
AbbVieSynthroid$163$1,33412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Rutherfordton

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →